Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Neoplastic Processes
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Neoplastic Processes
Tree Number(s)
C04.697
C23.550.727
Unique ID
D009385
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D009385
Annotation
general or unspecified; prefer specifics
Scope Note
The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.
Entry Version
NEOPL PROCESSES
Entry Term(s)
Processes, Neoplastic
NLM Classification #
QZ 203
Previous Indexing
specific neoplastic process (1966-1997)
Public MeSH Note
98
History Note
98; use explode 1982-97
Date Established
1998/01/01
Date of Entry
1981/05/19
Revision Date
2008/07/14
No Qualifiers
Neoplasms [C04]
Cysts [C04.182]
Hamartoma [C04.445]
Neoplasms by Histologic Type [C04.557]
Neoplasms by Site [C04.588]
Neoplasms, Experimental [C04.619]
Neoplasms, Hormone-Dependent [C04.626]
Neoplasms, Multiple Primary [C04.651]
Neoplasms, Post-Traumatic [C04.666]
Neoplasms, Radiation-Induced [C04.682]
Neoplasms, Second Primary [C04.692]
Neoplastic Processes [C04.697]
Anaplasia [C04.697.045]
Carcinogenesis [C04.697.098]
Neoplasm Invasiveness [C04.697.645]
Neoplasm Metastasis [C04.697.650]
Neoplasm Recurrence, Local [C04.697.655]
Neoplasm Regression, Spontaneous [C04.697.670]
Neoplasm, Residual [C04.697.700]
Oncogene Addiction [C04.697.850]
Neoplastic Syndromes, Hereditary [C04.700]
Paraneoplastic Syndromes [C04.730]
Precancerous Conditions [C04.834]
Pregnancy Complications, Neoplastic [C04.850]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Acantholysis [C23.550.035]
Arrhythmias, Cardiac [C23.550.073]
Ascites [C23.550.081]
Atrial Remodeling [C23.550.113]
Azotemia [C23.550.145]
Cardiotoxicity [C23.550.161]
Channelopathies [C23.550.177]
Chromosome Aberrations [C23.550.210]
Death [C23.550.260]
Dehydration [C23.550.274]
Delayed Graft Function [C23.550.277]
Disease [C23.550.288]
Disease Attributes [C23.550.291]
Dysbiosis [C23.550.308]
Emphysema [C23.550.325]
Extravasation of Diagnostic and Therapeutic Materials [C23.550.340]
Femoracetabular Impingement [C23.550.347]
Fibrosis [C23.550.355]
Frailty [C23.550.359]
Genomic Instability [C23.550.362]
Gliosis [C23.550.369]
Granuloma [C23.550.382]
Granulomatosis, Orofacial [C23.550.384]
Growth Disorders [C23.550.393]
Hemolysis [C23.550.403]
Hemorrhage [C23.550.414]
Hyperammonemia [C23.550.421]
Hyperamylasemia [C23.550.425]
Hyperbilirubinemia [C23.550.429]
Hyperplasia [C23.550.444]
Hyperuricemia [C23.550.449]
Hypovolemia [C23.550.455]
Inflammation [C23.550.470]
Intraoperative Complications [C23.550.505]
Ischemia [C23.550.513]
Leukoaraiosis [C23.550.522]
Leukocytosis [C23.550.526]
Lithiasis [C23.550.537]
Long Term Adverse Effects [C23.550.543]
Malacoplakia [C23.550.548]
Menstruation Disturbances [C23.550.568]
Metaplasia [C23.550.589]
Muscle Weakness [C23.550.695]
Myotoxicity [C23.550.706]
Necrosis [C23.550.717]
Neointima [C23.550.722]
Neoplastic Processes [C23.550.727]
Anaplasia [C23.550.727.045]
Carcinogenesis [C23.550.727.098]
Neoplasm Invasiveness [C23.550.727.645]
Neoplasm Metastasis [C23.550.727.650]
Neoplasm Recurrence, Local [C23.550.727.655]
Neoplasm Regression, Spontaneous [C23.550.727.670]
Neoplasm, Residual [C23.550.727.700]
Oncogene Addiction [C23.550.727.850]
Nerve Degeneration [C23.550.737]
Ochronosis [C23.550.744]
Ossification, Heterotopic [C23.550.751]
Ototoxicity [C23.550.753]
Pigmentation Disorders [C23.550.755]
Polydipsia [C23.550.759]
Postoperative Complications [C23.550.767]
Protein Aggregation, Pathological [C23.550.770]
Respiratory Aspiration [C23.550.773]
Retropneumoperitoneum [C23.550.794]
Sclerosis [C23.550.823]
Shock [C23.550.835]
Teratogenesis [C23.550.863]
Toxic Optic Neuropathy [C23.550.877]
Ulcer [C23.550.891]
Vascular Remodeling [C23.550.918]
Yang Deficiency [C23.550.945]
Yin Deficiency [C23.550.972]
Expand All
Collapse All
Neoplastic Processes
Preferred
Concept UI
M0014612
Scope Note
The pathological mechanisms and forms taken by tissue during degeneration into a neoplasm and its subsequent activity.
Terms
Neoplastic Processes
Preferred Term
Term UI
T028000
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1982)
Processes, Neoplastic
Term UI
T027999
Date
09/05/1996
LexicalTag
NON
ThesaurusID
NLM (1998)
page delivered in 0.238s